These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35911707)

  • 1. Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma.
    Zhao C; Xiong K; Adam A; Ji Z; Li X
    Front Immunol; 2022; 13():934494. PubMed ID: 35911707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.
    Zhong B; Wang Y; Liao Y; Liang J; Wang K; Zhou D; Zhao Y; Jiang N
    Apoptosis; 2023 Jun; 28(5-6):892-911. PubMed ID: 37000317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of necroptosis-related signature and tumor microenvironment infiltration characteristics in lung adenocarcinoma.
    Liu T; Guo L; Liu G; Dai Z; Wang L; Lin B; Hu X; Wang J; Zhang J
    Lung Cancer; 2022 Oct; 172():75-85. PubMed ID: 36027854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.
    Bi G; Chen Z; Yang X; Liang J; Hu Z; Bian Y; Sui Q; Li R; Zhan C; Fan H
    Cancer Immunol Immunother; 2020 Jul; 69(7):1293-1305. PubMed ID: 32189030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Prognostic Model Based on Seven Necroptosis-Related miRNAs for Predicting the Overall Survival of Patients with Lung Adenocarcinoma.
    Hong X; Wang G; Pei K; Mo C; Rong Z; Xu G
    Biomed Res Int; 2022; 2022():3198590. PubMed ID: 35372581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
    Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
    Front Oncol; 2022; 12():955186. PubMed ID: 35965497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma.
    Han T; Liu Y; Wu J; Bai Y; Zhou J; Hu C; Zhang W; Guo J; Wang Q; Hu D
    Sci Rep; 2023 Mar; 13(1):5153. PubMed ID: 36991102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
    Ke J; Cui J; Yang X; Du X; Ma B; Yu L
    Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma.
    Zhao Y; Shang J; Gao J; Han H; Gao Z; Yan Y; Zheng Q; Ye T; Fu F; Deng C; Ma Z; Zhang Y; Zheng D; Zheng S; Li Y; Cao Z; Shi L; Chen H
    Front Immunol; 2022; 13():921761. PubMed ID: 35844495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of lung adenocarcinoma classification and risk model based on necroptosis-related genes.
    Wu G; Feng D; Zhang Z; Zhang G; Zhang W
    Front Genet; 2022; 13():1037011. PubMed ID: 36452156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma.
    Huang H; Yu H; Li X; Li Y; Zhu G; Su L; Li M; Chen C; Gao M; Wu D; Zhang R; Cao P; Liu H; Chen J
    Front Immunol; 2022; 13():993890. PubMed ID: 36505472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential tumor antigens and immune subtypes for lung adenocarcinoma.
    Bai M; Liu X; Wang L
    Med Oncol; 2023 Feb; 40(3):100. PubMed ID: 36809467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma.
    Zhang J; He X; Hu J; Li T
    Front Genet; 2022; 13():920350. PubMed ID: 35754848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 19. Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma.
    Yao Y; Gu L; Zuo Z; Wang D; Zhou T; Xu X; Yang L; Huang X; Wang L
    Front Oncol; 2022; 12():1010976. PubMed ID: 36605426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.